向皮质向传输用于治疗大麻素使用障碍
Sergi Ferré1, Attila Köfalvi2, Francisco Ciruela3
1Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA.
Trends in pharmacological sciences
|June 18, 2023
概括
大麻素的奖励效应不仅仅涉及CB1受体. 新的研究突出显示,前额皮质状管道和A2A受体是治疗大麻素使用障碍的关键标.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统上,大麻素CB1受体 (CB1Rs) 通过腹膜区域 (VTA) 的多巴胺基神经元消抑制与奖励效应有关.
- 这种模型不足以解释大麻素诱导的厌恶效应和腺素A2A受体 (A2AAR) 抗剂在抵消THC自给的效果.
研究的目的:
- 提出和审查证据,以证明前额皮质向性谷氨基基传输参与调解大麻素效应.
- 确定皮质星细胞CB1Rs和条状A2AAR异构体作为关键机制和潜在的治疗点,用于大麻素使用障碍 (CUD).
主要方法:
- 审查最近的动物实验和人类成像研究.
- 对皮质星细胞CB1Rs在皮质状血管路径激活中的作用的证据分析.
- 检查A2AAR异构体在排列性谷氨基基终端中介抗体效应的检查.
主要成果:
- 大麻素效应,无论是奖励还是厌恶,都不仅仅是由VTA多巴胺基神经元介导的.
- 额叶皮质干干传输的激活是一个重要的机制.
- 皮质星细胞CB1Rs和条状A2AAR异构体与大麻素的复杂作用有关.
结论:
- 大麻素的奖励和厌恶作用涉及比VTA中简单的CB1R激活之外的复杂相互作用.
- 额叶皮质干干性谷氨基基通路,涉及皮质干性星状细胞CB1Rs和干性A2AAR异构体,至关重要.
- 针对这些途径为管理大麻素使用障碍 (CUD) 提供了有希望的治疗策略.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
272
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
272
Psychosis: Goals of Pharmacotherapy
172
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
172
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
327
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
327
Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
Drug Therapy
74
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
74


